LF

RNDr. Martin Kello, PhD.   SK

Email:
martin.kello@upjs.sk
Homepage:
https://www.upjs.sk/LF/zamestnanec/martin.kello
Faculty:
LF UPJŠ - Pavol Jozef Šafárik University in Košice Faculty of Medicine
Department:
UFR - Department of Pharmacology
Office:
MA4O12
Phone:
+421 55 234 3532
ORCID ID:
https://orcid.org/0000-0002-2454-5799
RNDr. Martin Kello, PhD. - independent researcher, author and co-author of 85 scientific articles in CC journals, with 1851 SCI citations, H-index = 25 (WoS). The main area of his scientific work is the study of the tumor microenvironment and the effects of natural and synthetic substances as potential anticancer drugs. He is responsible for experimental design, flow cytometry, fluorescence microscopy, cell imaging, data analysis and interpretation of results.

Higher education and further qualification growth
Second degree of higher education:
P.J. Šafárik University in Košice, Faculty of Natural Science, 2006, Biology-Cellular and Molecular biology and Genetics
Third degree of higher education:
P.J. Šafárik University in Košice, Faculty of Natural Science, 2010, Biology- Genetics

Research /art/ teacher profile

Display details  
Profile courses
Pharmacology - Public health, I. degree
Pharmacology - Nursing, I. degree
Pharmacology - Physiotherapy, I. degree
Selected publications

ADC - KUBATKA, P., URAMOVÁ, S., KELLO, M., KAJO, K., ZUBOR, P., MOJŽIŠ, J., LASABOVÁ, S., PÉČ, M., ADAMKOV, M., DANKO, J.. Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma. Journal of Cellular and Molecular Medicine, 2017, 21(11), pp. 2837-2851 IF 4.938, Q1, Citated 26x

ADC - BUJŇÁKOVÁ, Z., KELLO, M., KOVÁČ, J., TÓTHOVÁ, E., SHPOTYUK, O., BALÁŽ, P., MOJZIS, J., & ANDREJKO, S. (2020). Preparation of As4S4/Fe3O4 nanosuspensions and in-vitro verification of their anticancer activity. Materials Science and Engineering: C, Volume: 110 Pages: 10683-10683, IF 4.959, Q1, Citated 1x

ADM - KELLO, M., TAKAC, P., KUBATKA, P., KURUC, T., PETROVA, K., & MOJZIS, J. (2020). Oxidative Stress-Induced DNA Damage and Apoptosis in Clove Buds-Treated MCF-7 Cells. Biomolecules, 10(1), 139, IF 4.694, Q1, Citated 6x

ADC - KUBATKA, P., KELLO, M., KAJO, K., SAMEC, M., LISKOVA, A., JASEK, K., KOKLESOVA, L., KURUC, T., ADAMKOV, M., SMEJKAL, K., SVAJDLENKA, E., SOLAR, P., PEC, M., BUSSELBERG, D., SADLONOVA, V. & MOJZIS, J. (2021). Rhus coriaria L.(Sumac) Demonstrates Oncostatic Activity in the Therapeutic and Preventive Model of Breast Carcinoma. International Journal of Molecular Sciences, 22(1), 183, IF 4.556, Q1, Citated 9x

ADM - KELLO, M., KURUC, T., PETROVA, K., GOGA, M., MICHALOVA, Z., COMA, M., RUCOVA, D. & MOJZIS, J. (2021). Pro-Apoptotic Potential of Pseudevernia furfuracea (L.) Zopf Extract and Isolated Physodic Acid in Acute Lymphoblastic Leukemia Model In Vitro. Pharmaceutics, 13(12), 2173. IF 6.321, Q1, Citated 0x

Selected projects

APVV-16-0446 Cell interactions in the tumor microenvironment and their pharmacological modulation, investigator

VEGA MŠ SR A SAV 1/0753/17 Influence of natural substances on tumor microenvironment, investigator

VEGA MŠ SR A SAV 1/0653/19 Secondary metabolites of lichens: promising modulators of the tumor microenvironment?, principal investigator

ITMS: 26220220185 MediPark- Medical University Science Park in Košice, investigator

ITMS2014 +: 313011V455 "Open Scientific Community for Modern Interdisciplinary Research in Medicine (OPENMED)", investigator

Organisational activities
member - Slovak Pharmacological Society, since 2018
member - Medical Association of Košice, since 2018
member - EACR - European Cancer Research Association, since 2018
associated editor - BMC Complementary Medicine and Therapies, since 2018

Additional information

Awards
2010 Award of the Dean for outstanding research, publishing and pedagogical activities of PhD. students
Projects
Agency for the Promotion of Research and Development Project “Open Scientific Community for Modern Interdisciplinary Research in Medicine (OPENMED)”, code ITMS2014+: 313011V455, co-financed by the European Regional Development Fund. APVV-16-0446: Cellular interactions in the tumor microenvironment and their pharmacological modulation. ITMS: 26220220185 MediPark – Medical University Science Park in Košice. NFP26110230192: Innovation and implementation of new forms of education at the Faculty of Health Sciences, University of Prešov. 003/2012/1.2/OPV ITMS: 26110230069: Acceleration of human resources development in science and research, innovation, and quality improvement of the educational process. APVV 0716-10: Molecular-genetic aspects of complex diseases in the Slovak Roma population. ITMS: 26220120041 / OP Research and Development: Expansion of the Centre of Excellence for Animal and Human Ecology with an emphasis on improving scientific research – Stage II. ITMS: 26220220013 / OP Research and Development: Use of research and development for breeding new cultivars (prototypes) of medicinal plants and their varietal registration. VVCE-0001-07: Center for Signal Research. APVV-0321-07: Hypericum spp. as a source of bioactive compounds with antitumor activity. APVT-20-003704: Hypericum perforatum L.: Genetic aspects of hypericin synthesis and its photocytotoxic effects. Scientific Grant Agency of the Ministry of Education of the Slovak Republic and the Slovak Academy of Sciences (VEGA) VEGA 1/0436/24: Increasing chemosensitivity of pancreatic ductal adenocarcinoma by targeting tumor-associated fibroblasts. (co-investigator, deputy) VEGA 1/0498/23: Modulation of the breast cancer tumor microenvironment by secondary metabolites of lichens: an in vitro study. (principal investigator) VEGA 1/0539/21: Fibroblasts and tumor microenvironment: cell interactions and their pharmacological modulation. (co-investigator) VEGA 1/0319/20: Development of active wound dressings based on hydrogels containing plant extracts stimulating wound healing in healthy and diabetic rats. (co-investigator, deputy) VEGA 1/0653/19: Secondary metabolites of lichens: promising modulators of the tumor microenvironment? (principal investigator) VEGA 1/0753/17: The effect of natural compounds on the tumor microenvironment. (co-investigator) VEGA 1/0546/16: Antiproliferative effects of newly synthesized jaspine B analogs and their effect on tumor angiogenesis. (co-investigator) VEGA 1/2329/05: Role of lipid mediators in hypericin-modulated proliferation and apoptosis of cancer cells. (co-investigator) VEGA 1/0240/08: Effect of (phospho)lipid membrane composition changes on the proliferation and survival of colorectal epithelial cancer cells in an experimental cancer therapy model. (co-investigator) International Scientific and Technical Cooperation MVTS Bil/CZ/SR/SK-75/06: Effect of modulation of phospholipid metabolism on the proliferation and apoptosis of tumor cells in interaction with cytotoxic agents. Internal Scientific Grant System of Pavol Jozef Šafárik University VVGS PF 22/2007/B: Exogenous administration of arachidonic acid and other polyunsaturated fatty acids and modulation of apoptosis in combination with photodynamic therapy on a tumor model. VVGS PF 3/2009/B: Effect of exogenous modulation of phospholipid membrane composition by polyunsaturated fatty acids on the sensitivity of tumor cells in vitro to photodynamic therapy.
Interesting links
https://www.eacr.org/

Further information


LF